Start with the biggest number: Moderna jumped roughly 70% premarket, and Merck rode along for +10%, after their mRNA shot showed it could stop melanoma from coming back in a Phase 3 trial. That's a different claim than 'this vaccine treats cancer' — it's 'this vaccine, given after treatment, kept the cancer from returning.' Same platform that made COVID shots, pointed at a much harder problem, with a real trial behind it. Worth the pop.
Then there's SK Hynix, which got hit almost 10% in a day and responded by announcing a nearly $29 billion buyback — that's a company using its own cash to buy back its own shares, a bet that the stock is cheaper than the business. Management putting that much money where its mouth is, right after a selloff, is a louder signal than any analyst note.
And the one I keep chewing on: Citadel quietly unwound about 80% of its own 'AI hype' portfolio — roughly $4 billion — the same fund it built up after calling the AI trade good. One firm's opinion has swung this narrative both directions already. Watching the people who were loudest go quiet is, at minimum, a fact worth sitting with.